Novartis’ Entresto Gains US FDA Panel Nod For New Heart Failure Claim

 
• By Sue Sutter
  
metronome with heart
FDA’s cardio-renal committee voted 12-1 in favor of a new heart failure claim for Entresto. • Source: Getty
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers